DaVita Competitors
| DVA Stock | USD 109.34 2.10 1.96% |
DaVita HealthCare vs Henry Schein Correlation
Excellent diversification
The correlation between DaVita HealthCare Partners and HSIC is -0.63 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding DaVita HealthCare Partners and HSIC in the same portfolio, assuming nothing else is changed.
Moving together with DaVita Stock
Moving against DaVita Stock
| 0.81 | IFSPF | Interfor | PairCorr |
| 0.78 | LILIF | Argentina Lithium Energy | PairCorr |
| 0.65 | VFC | VF Corporation | PairCorr |
| 0.6 | RHC | Ramsay Health Care | PairCorr |
| 0.55 | CON | Concentra Group Holdings | PairCorr |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DaVita HealthCare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
DaVita HealthCare Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between DaVita HealthCare and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of DaVita and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of DaVita HealthCare does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between DaVita Stock performing well and DaVita HealthCare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze DaVita HealthCare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ENSG | 1.01 | (0.15) | 0.00 | (0.20) | 0.00 | 2.51 | 6.93 | |||
| ALGN | 1.45 | 0.23 | 0.18 | 0.18 | 1.21 | 4.53 | 10.81 | |||
| UHS | 1.24 | (0.12) | 0.00 | (0.11) | 0.00 | 2.49 | 8.92 | |||
| ATR | 1.01 | (0.07) | 0.00 | (0.21) | 0.00 | 1.73 | 6.75 | |||
| BIO | 1.34 | (0.24) | 0.00 | (0.15) | 0.00 | 4.31 | 8.43 | |||
| CHE | 1.10 | (0.03) | 0.00 | (0.04) | 0.00 | 2.25 | 11.15 | |||
| MOH | 1.93 | 0.13 | 0.05 | 0.14 | 2.95 | 3.97 | 13.66 | |||
| RVMD | 2.31 | 0.88 | 0.23 | (7.81) | 2.99 | 4.56 | 45.50 | |||
| BMRN | 1.63 | 0.11 | 0.06 | 0.20 | 1.58 | 3.20 | 22.06 | |||
| HSIC | 1.27 | 0.25 | 0.16 | 0.45 | 1.24 | 2.43 | 13.60 |
Cross Equities Net Income Analysis
Compare DaVita HealthCare and related stocks such as Ensign Group, Align Technology, and Universal Health Services Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENSG | 3.6 M | 47.7 M | 40.6 M | 24 M | 36 M | 55.4 M | 50 M | 40.5 M | 92.4 M | 110.5 M | 170.5 M | 194.7 M | 224.7 M | 209.4 M | 298 M | 342.7 M | 359.8 M |
| ALGN | (15.4 M) | 66.7 M | 58.7 M | 64.3 M | 145.8 M | 144 M | 189.7 M | 231.4 M | 400.2 M | 442.8 M | 1.8 B | 772 M | 361.6 M | 445.1 M | 421.4 M | 484.6 M | 508.8 M |
| UHS | 21.7 M | 398.2 M | 443.4 M | 510.7 M | 545.3 M | 680.5 M | 702.4 M | 752.3 M | 779.7 M | 814.9 M | 944 M | 991.6 M | 675.6 M | 717.8 M | 1.1 B | 1.3 B | 1.4 B |
| ATR | 19.5 M | 183.7 M | 162.6 M | 172 M | 191.7 M | 199.3 M | 205.6 M | 220 M | 194.7 M | 242.2 M | 214 M | 244.1 M | 239.3 M | 284.5 M | 374.5 M | 430.7 M | 452.3 M |
| BIO | 4.3 M | 178.2 M | 169.2 M | 77.8 M | 88.8 M | 113.1 M | 28.1 M | 114.7 M | 361 M | 1.8 B | 3.8 B | 4.3 B | (3.6 B) | (637.3 M) | (1.8 B) | (2.1 B) | (2 B) |
| CHE | 21.9 M | 86 M | 89.3 M | 77.2 M | 99.3 M | 110.3 M | 108.7 M | 98.2 M | 205.5 M | 219.9 M | 319.5 M | 268.6 M | 249.6 M | 272.5 M | 302 M | 347.3 M | 364.7 M |
| MOH | 9.5 M | 20.8 M | 9.8 M | 52.9 M | 62.2 M | 143 M | 8 M | (512 M) | 707 M | 737 M | 673 M | 659 M | 792 M | 1.1 B | 1.2 B | 1.4 B | 1.4 B |
| RVMD | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (41.8 M) | (47.7 M) | (108.2 M) | (187.1 M) | (248.7 M) | (436.4 M) | (600.1 M) | (540.1 M) | (513.1 M) |
| BMRN | (12.3 M) | (53.8 M) | (114.3 M) | (176.4 M) | (134 M) | (171.8 M) | (630.2 M) | (117 M) | (77.2 M) | (23.8 M) | 854 M | (64.1 M) | 141.6 M | 167.6 M | 426.9 M | 26.8 M | 28.1 M |
| HSIC | (10.9 M) | 367.7 M | 388.1 M | 444.1 M | 466.1 M | 479.1 M | 506.8 M | 406.3 M | 535.9 M | 508 M | 402.2 M | 623.9 M | 538 M | 416 M | 390 M | 448.5 M | 301.7 M |
DaVita HealthCare and related stocks such as Ensign Group, Align Technology, and Universal Health Services Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in DaVita HealthCare financial statement analysis. It represents the amount of money remaining after all of DaVita HealthCare Partners operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.DaVita HealthCare Competitive Analysis
The better you understand DaVita HealthCare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, DaVita HealthCare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across DaVita HealthCare's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
DaVita HealthCare Competition Performance Charts
Five steps to successful analysis of DaVita HealthCare Competition
DaVita HealthCare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by DaVita HealthCare in relation to its competition. DaVita HealthCare's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of DaVita HealthCare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact DaVita HealthCare's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to DaVita HealthCare, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your DaVita HealthCare position
In addition to having DaVita HealthCare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run FinTech Thematic Idea Now
FinTech
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 67 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
| View All Next | Launch |
Check out DaVita HealthCare Correlation with its peers. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. Projected growth potential of DaVita fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive DaVita HealthCare assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.18) | Earnings Share 9.88 | Revenue Per Share | Quarterly Revenue Growth 0.048 | Return On Assets |
Understanding DaVita HealthCare requires distinguishing between market price and book value, where the latter reflects DaVita's accounting equity. The concept of intrinsic value—what DaVita HealthCare's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push DaVita HealthCare's price substantially above or below its fundamental value.
It's important to distinguish between DaVita HealthCare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DaVita HealthCare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, DaVita HealthCare's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.